SCHEMBL17282299

SCHEMBL17282299

Cc1ccccc1NC(=O)Nc1ccc(-c2cn(C)c3cnccc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IMPDH2 P12268 1/20 0.53
▸ NFATC1 O95644 1/20 0.52
▸ GSK3B P49841 1/20 0.52
▸ DYRK1A Q13627 1/20 0.52
▸ KDR P35968 8/20 0.49
▸ KIT P10721 2/20 0.49
▸ PDGFRA P16234 1/20 0.49
▸ AURKB Q96GD4 2/20 0.47
▸ FLT3 P36888 2/20 0.46
▸ DDX3X O00571 3/20 0.46
▸ PDGFRB P09619 1/20 0.45
▸ PLK4 O00444 1/20 0.45
▸ AURKA O14965 1/20 0.45
▸ ROCK2 O75116 1/20 0.45
▸ MAP4K4 O95819 1/20 0.45
▸ LCK P06239 1/20 0.45
▸ LYN P07948 1/20 0.45
▸ RET P07949 1/20 0.45
▸ MET P08581 1/20 0.45
▸ FGFR1 P11362 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15548150 0.87 SMN1; SMN2 (0.58) NFATC1GSK3BDYRK1AKDRPDGFRA
SCHEMBL17282298 0.86 DYRK1A (0.48) IMPDH2NFATC1GSK3BDYRK1AKDR
SCHEMBL15550098 0.83 DYRK1A (0.63) NFATC1GSK3BDYRK1AS1PR1S1PR3
SCHEMBL15548085 0.77 DYRK1A (0.42) IMPDH2NFATC1GSK3BDYRK1APDGFRA
SCHEMBL15547534 0.75 AHR (0.56) KDRPDGFRAMAPTRAB9AKMT2A
SCHEMBL17286122 0.75 DYRK1A (0.55) NFATC1GSK3BDYRK1AMAP4K4S1PR1
SCHEMBL17282300 0.73 AHR (0.48) NFATC1GSK3BDYRK1AKDRPDGFRA
SCHEMBL17282297 0.73 DYRK1A (0.79) NFATC1GSK3BDYRK1AKDR
SCHEMBL20379377 0.71 NAMPT (0.53) MAPTRAB9AKMT2ANPC1MEN1
SCHEMBL1880857 0.71 MAP2 (0.62) IMPDH2KDRKITPDGFRAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150336948-A1 Isotopically Labeled Biaryl Urea Compounds MERCK SHARPE & DOHME CORP. 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336948-A1 Isotopically Labeled Biaryl Urea Compounds MAPT, SLC14A1, UBTF IMPDH2 566/4885NFATC1 3349/4885GSK3B 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback